Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties - Dreger, Peter; Dietrich, Sascha (Bone marrow transplantation, 2019)
Gesehen am 14.06.2019